-
Take the burn out of sunscreen testing
Exposing humans to ultraviolet radiation to test sunscreen effectiveness should be phased out, according to scientists and cancer experts. -
ARPANSA updates radiation dose conversion factors
Calculating exposure from naturally occurring radioactive material (NORM) has been standardised by the Australian Radiation Protection and Nuclear Safety Agency to encourage national uniformity and ongoing alignment with international best practice. -
ARPANSA Boosts UV Protection Globally
ARPANSA has teamed up with Cancer Council Victoria and the Australian Bureau of Meteorology to create a SunSmart Global UV app. -
ARPANSA releases advisory note on public health considerations for disposal of radioactive waste
ARPANSA has released an advisory note on the public health considerations for disposal of radioactive waste. -
-
ARPANSA leads world first in film dosimetry
ARPANSA is working with the International Atomic Energy Agency (IAEA) and dosimetry auditors globally to develop a world first film dosimetry intercomparison tool. -
Laser focus on illegal imports
Illegal laser pointers that are being imported into the country due to incorrect product labelling is an issue being pinpointed to Australia’s Freight and Trade Alliance this month by ARPANSA scientist Dr Chris Brzozek. -
Recruitment underway for ARPANSA Chief Radiation Health Scientist and Head of Radiation Health Services Branch
Recruitment is currently underway for the next Chief Radiation Health Scientist and Head of Radiation Health Services Branch of ARPANSA. -
ARPANSA and RMIT to collaborate on new EME research
ARPANSA has provided funding to RMIT to investigate the impact of non-ionising radiation on cell permeability. This research is funded as the first ‘major project’ under ARPANSA’s new EME Program Research Framework. -
ARPANSA reviews risks of cosmetic procedures
ARPANSA experts have published an article in Public Health Research and Practice, a journal of the Sax Institute, that calls for more research into the use of non-ionising radiation for cosmetic purposes. -
ARPANSA farewells CEO Carl-Magnus Larsson and welcomes new CEO Gillian Hirth
The Australian Government announces the appointment of Dr Gillian Hirth as Chief Executive Officer (CEO) of ARPANSA following the retirement of current CEO, Dr Carl-Magnus Larsson. -
ARPANSA approves siting licence for ANSTO waste facility
ARPANSA has issued a licence to the Australian Nuclear Science and Technology Organisation (ANSTO) to prepare a site for the Intermediate Level Waste Capacity Increase (ILWCI) facility. -
Study shows sunscreen saves skin
A review led by ARPANSA has shown that sunscreen is safe to use and, when applied correctly, reduces the risk of skin cancer and sunburn. -
Developing the next generation of nuclear safety professionals
ARPANSA announces applications are open for the Australian Public Service Graduate Program. -
Ensuring accurate dose for radiotherapy
Dose accuracy is critical to safe cancer treatment. Dosimetry audits provide assurance that the radiation dose delivered to the patient aligns with the planned dose. -
Aerosol sunscreens inadequate for UV coverage
ARPANSA and the Cancer Council of Victoria have advised Australians to avoid using aerosol sunscreens and stick with creams and lotions for UV protection. -
Report highlights learnings from nuclear medicine incidents
ARPANSA has finalised its report on 2020 radiation safety incidents using data collated from radiation regulators around the country. -
ARPANSA begins world-first review of radio wave environmental impacts
In another world first, ARPANSA and Swinburne University have joined forces to produce a systematic map of the scientific evidence into the impact of radio waves on the environment.
